PDE10A

Chr 6ARAD

phosphodiesterase 10A

Also known as: ADSD2, HSPDE10A, IOLOD, PDE10A19

The protein encoded by this gene belongs to the cyclic nucleotide phosphodiesterase family. It plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. This protein can hydrolyze both cAMP and cGMP to the corresponding nucleoside 5' monophosphate, but has higher affinity for cAMP, and is more efficient with cAMP as substrate. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Dec 2011]

OMIMResearchGenerating clinical summary…
MultiplemechanismAR/ADLOEUF 0.212 OMIM phenotypes
Clinical SummaryPDE10A
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
13 unique Pathogenic / Likely Pathogenic· 136 VUS of 310 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.21LOEUF
pLI 1.000
Z-score 5.51
OE 0.09 (0.040.21)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
3.76Z-score
OE missense 0.50 (0.450.56)
222 obs / 445.1 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.09 (0.040.21)
00.351.4
Missense OE?0.50 (0.450.56)
00.61.4
Synonymous OE?0.97
01.21.6
LoF obs/exp: 4 / 43.0Missense obs/exp: 222 / 445.1Syn Z: 0.26
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongPDE10A-related childhood-onset chorea with bilateral striatal lesionsOTHERAD

This gene — mechanism propensity

DN
0.5378th %ile
GOF
0.6541th %ile
LOF
0.56top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF38% of P/LP variants are LoF · LOEUF 0.21
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

310 submitted variants in ClinVar

Classification Summary

Pathogenic4
Likely Pathogenic9
VUS136
Likely Benign117
Benign21
Conflicting4
4
Pathogenic
9
Likely Pathogenic
136
VUS
117
Likely Benign
21
Benign
4
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
3
0
0
4
Likely Pathogenic
4
5
0
0
9
VUS
12
111
9
4
136
Likely Benign
0
4
52
61
117
Benign
0
0
11
10
21
Conflicting
4
Total171237275291

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

48 pathogenic / likely-pathogenic (of 60) ClinVar copy-number / structural variants overlap PDE10A — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PDE10A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.